Quick Comparison
| Argireline (Acetyl Hexapeptide-3) | Matrixyl (Palmitoyl Pentapeptide-4) | |
|---|---|---|
| Typical Concentration | Typically used at 5-10% concentration. Apply twice daily to expression line areas (forehead, around eyes, between brows). Effects visible after 2-4 weeks. Must be used continuously — effects reverse when stopped. | Typically used at 2-8% in formulations. Applied morning and/or night. Compatible with virtually all other active ingredients. Often found combined with Matrixyl 3000 (palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7) for enhanced effects. |
| Application | Topical (serum, cream). Water-soluble. Apply directly to expression line areas. | Topical (serum, cream). Water-soluble base. Apply to clean skin. Compatible with acids, retinoids, and vitamin C. |
| Research Papers | 10 papers | 2 papers |
| Categories |
Mechanism of Action
Argireline (Acetyl Hexapeptide-3)
Argireline (acetyl hexapeptide-3) mimics the C-terminal region of SNAP-25, a core SNARE complex component. The SNARE complex (SNAP-25, syntaxin, synaptobrevin) mediates vesicle fusion at the neuromuscular junction for acetylcholine release. Argireline competes with SNAP-25 for syntaxin binding, partially disrupting SNARE assembly and reducing neurotransmitter exocytosis. This decreases acetylcholine release and attenuates facial muscle contraction intensity. The effect is dose-dependent, localized, and reversible—unlike botulinum toxin's enzymatic cleavage of SNAP-25. Clinical studies show ~30% wrinkle reduction versus 80%+ with injectable neurotoxins. Provides non-invasive expression line softening.
Matrixyl (Palmitoyl Pentapeptide-4)
Matrixyl (palmitoyl pentapeptide-4, Pal-KTTKS) is a matrikine—a bioactive collagen fragment mimicking Lys-Thr-Thr-Lys-Ser from the alpha-1 chain of collagen I. This sequence binds integrin receptors on dermal fibroblasts, triggering TGF-beta/Smad and MAPK/ERK signaling that upregulates ECM synthesis genes. Fibroblasts increase production of collagen I, III, IV, fibronectin, elastin, and glycosaminoglycans including hyaluronic acid—recreating the wound-healing signal without tissue damage. The C16 palmitoyl chain enhances lipophilicity and stratum corneum penetration via intercellular lipid partitioning. Unlike retinoids, Matrixyl does not accelerate epidermal turnover, explaining its lack of irritation. Clinical studies show wrinkle reduction comparable to retinol.
Risks & Safety
Argireline (Acetyl Hexapeptide-3)
Common
Very well-tolerated. Occasional mild tingling.
Serious
None documented.
Rare
Allergic reaction. At very high concentrations, some users report a slight 'droopy' feeling in the treated area.
Matrixyl (Palmitoyl Pentapeptide-4)
Common
Essentially none — peptides are extremely well-tolerated.
Serious
None documented. Safe in pregnancy.
Rare
Minimal risk of allergic reaction.
Full Profiles
Argireline (Acetyl Hexapeptide-3) →
Known as 'topical Botox,' Argireline is a peptide that reduces the appearance of expression lines by partially inhibiting the SNARE complex — the same mechanism targeted by botulinum toxin, but through topical application rather than injection. The effect is much milder than Botox (roughly 30% wrinkle reduction vs 80%+) but provides a non-invasive option for forehead lines, crow's feet, and frown lines.
Matrixyl (Palmitoyl Pentapeptide-4) →
One of the most studied anti-aging peptides. Matrixyl is a signal peptide that mimics collagen fragments (matrikines), tricking fibroblasts into thinking collagen has been broken down and needs to be replaced. This stimulates new collagen, elastin, and hyaluronic acid production. Clinical studies show visible wrinkle reduction comparable to retinol but without any irritation.